Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OCUL

Ocular Therapeutix Inc

May 22 • 04:00PM ET

8.23

+0.01 0.12 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: EYPT RGNX KOD OCGN OPK

| Held by: VTI IWM VXF IWO VTWO PJP SCHA XPH DFAS VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.46	Insider Own	9.58%	Shs Outstand	218.90M	Perf Week	-10.15%
Market Cap	1.80B	Forward P/E	-	EPS next Y	-1.45	Insider Trans	-0.78%	Shs Float	199.75M	Perf Month	-14.18%
Enterprise Value	1.21B	PEG	-	EPS next Q	-0.38	Inst Own	89.17%	Short Float	12.41%	Perf Quarter	-2.14%
Income	-290.50M	P/S	34.63	EPS this Y	-9.45%	Inst Trans	1.29%	Short Ratio	6.07	Perf Half Y	-31.98%
Sales	52.04M	P/B	3.10	EPS next Y	6.92%	ROA	-51.03%	Short Interest	24.79M	Perf YTD	-32.21%
Book/sh	2.66	P/C	2.70	EPS next 5Y	2.78%	ROE	-68.55%	52W High	16.44 -49.94%	Perf Year	14.07%
Cash/sh	3.04	P/FCF	-	EPS past 3/5Y	-15.40% 11.13%	ROIC	-44.16%	52W Low	6.23 32.10%	Perf 3Y	26.42%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.29% 24.45%	Gross Margin	87.24%	Volatility	5.74% 4.88%	Perf 5Y	-40.15%
Dividend TTM	-	EV/Sales	23.34	EPS Y/Y TTM	-26.75%	Oper. Margin	-575.42%	ATR (14)	0.47	Perf 10Y	-24.50%
Dividend Ex-Date	-	Quick Ratio	14.73	Sales Y/Y TTM	-12.76%	Profit Margin	-558.24%	RSI (14)	37.53	Recom	1.08
Dividend Gr. 3/5Y	- -	Current Ratio	14.81	EPS Q/Q	-4.58%	SMA20	-9.84%	Beta	0.89	Target Price	26.17
Payout	-	Debt/Eq	0.14	Sales Q/Q	0.81%	SMA50	-6.93%	Rel Volume	0.50	Prev Close	8.22
Employees	325	LT Debt/Eq	0.13	Earnings	May 05 BMO	SMA200	-24.05%	Avg Volume	4.08M	Price	8.23
IPO	Jul 25, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-27.06% -15.23%	Trades		Volume	2,024,186	Change	0.12%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)